Replies to post #79710 on Ocata Therapeutics Inc fka OCAT

[farviewhill]

That's a possibility, but I inclined to think a variety of factors have already diluted any major negative effects to share price, like; an assured infusion of capital to insure the company's viability going forward and especially to begin the all crucial phase 2, which historically has been the phase of institutional buying (combined with a new uplisted nasdaq platform) and also the recent run to the mid 12.00 range and then it's correction, as some have noted, may well be the anticipated dilution factoring in dynamic you've referred to in the share price.
Timed will ell. I still think that we're at a stage where the potential good news, for the reasons i stated and others, will provide strength to the stock as a result of significant new acquisition of shares.